JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 24, 2008; DOI: 10.1124/jpet.108.140913


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.140913v1
326/3/783    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strasser, A.
Right arrow Articles by Seifert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strasser, A.
Right arrow Articles by Seifert, R.


Received for publication May 7, 2008.
Revised June 20, 2008.
Accepted for publication June 23, 2008.

Ligand-Specific Contribution of the N-Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor

Andrea Strasser 1*, Hans-Joachim Wittmann 1, Roland Seifert 1

1 University of Regensburg

* Address correspondence to: E-mail: andrea.strasser{at}chemie.uni-regensburg.de

Abstract

There are species-differences between human histamine H1 receptor (hH1R) and guinea pig histamine H1 receptor (gpH1R) for phenylhistamines and histaprodifens. Several studies showed participation of the second extracellular loop (E2-loop) in ligand-binding for some G-protein-coupled receptors (GPCRs). Because there are large species-differences in amino acid sequence between hH1R and gpH1R for the N-terminus and E2-loop, we generated chimeric hH1Rs with gp-E2-loop (hgpE2H1R) and gp-N-terminus and gp-E2-loop (hgpNgpE2H1R). hH1R, gpH1R and chimeras were expressed in Sf9 insect cells. [3H]Mepyramine binding assays and steady-state GTPase assays were performed. In the series hH1R > hgpE2H1R > hgpNgpE2H1R we observed a significant decrease in potency of histamine 1 in the GTPase assay. For phenoprodifen 5 and the chiral phenoprodifens 6R and 6S a significant decrease in affinity and potency was found in the series hH1R > hgpE2H1R > hgpNgpE2H1R. Additionally, we constructed new active-state H1R models based on the crystal structure of the human{beta}2-adrenergic receptor. Compared to the H1R active-state models based on the crystal structure of bovine rhodopsin, the E2-loop differs in its contact to the ligand bound in the binding pocket. In the bovine rhodopsin based model, the backbone carbonyl of Lys-187 (gpH1R) interacts with large histaprodifens in the binding pocket, but in the h{beta}2AR based model Lys-187 (gpH1R) is located distantly from the binding pocket. In conclusion, the differences in N-terminus and E2-loop between hH1R and gpH1R exert an influence on affinity and/or potency for histamine and phenoprodifens 5, 6R and 6S.


Key words: GPCR, Histamine H1-Receptor, Histaprodifen, N-Terminus, Phenoprodifen, second extracellular loop





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.